Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study
Rafique Z, Budden J, Quinn C, Duanmu Y, Safdar B, Bischof J, Driver B, Herzog C, Weir M, Singer A, Boone S, Soto-Ruiz K, Peacock W. Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): design of a multicentre, randomised, double-blind, placebo-controlled, parallel-group study. BMJ Open 2023, 13: e071311. PMID: 37308268, PMCID: PMC10277034, DOI: 10.1136/bmjopen-2022-071311.Peer-Reviewed Original ResearchConceptsNet clinical benefitInstitutional review boardProportion of participantsAdjunct treatmentClinical benefitMean changePlacebo-controlled studyParallel-group studySingle oral doseEmergency department managementLocal institutional review boardCentral institutional review boardSeverity of changesPrimary endpointSafety endpointSecondary endpointsAdverse eventsSerum potassiumOral doseSecond doseSerum KStudy completionTreatment protocolAdditional interventionsCommon treatment